Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
Autor: | David Swanson, Norman J. Carr, Thale Dawn J.H. Patrick-Brown, Kjersti Flatmark, Stein Gunnar Larsen, Faheez Mohamed |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Peritoneal Surface Malignancy
medicine.medical_specialty education.field_of_study business.industry Norway Incidence (epidemiology) Population Prevalence Disease medicine.disease Pseudomyxoma Peritonei Europe Oncology Epidemiology medicine Pseudomyxoma peritonei Humans Surgery education business Peritoneal Neoplasms Demography |
Zdroj: | Annals of Surgical Oncology |
ISSN: | 1534-4681 1068-9265 |
Popis: | Background The determination of the incidence and prevalence of rare diseases is important for economists and health-care providers. Pseudomyxoma peritonei (PMP) is a rare, slow-growing abdominal cancer that represents a substantial burden on both patients and health-care systems. The incidence rate was previously approximated at 1–2 people per million per year; this incidence has never been challenged, and the prevalence has not been estimated. Methods Epidemiological data from Norway and England were obtained and analysed to calculate a minimum incidence rate based on the number of patients having a first surgical intervention for PMP. A novel method was then used to determine a prevalence rate for PMP, incorporating incidence, death, and cure rates in a multi-year analysis that accounted for the increasing population of Europe over a 10-year period. Results An incidence rate of 3.2 people per million per year was calculated, with a corresponding estimated prevalence rate of 22 people per million per year. By this calculation, 11,736 people in Europe were estimated to be living with PMP in 2018. Conclusion Incidence and prevalence are essential tools for assessment of the financial and human cost of a disease. For rare diseases, such as PMP, the lack of accurate registries presents a particular challenge in determining such health-related statistical parameters. Based on our calculations, a significant number of people are living with PMP in Europe, underlining the need for appropriate resource allocation to ensure that adequate health-care measures are provided. |
Databáze: | OpenAIRE |
Externí odkaz: |